Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate

scientific article published on 25 January 2016

Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/1940-6207.CAPR-15-0370-T
P932PMC publication ID4818696
P698PubMed publication ID26811335

P2093author name stringMichael N Gould
Jenny E Gumperz
Nicholas A Zumwalde
Deepak Sharma
Lee G Wilke
Jill D Haag
Jennifer A Mirrielees
P2860cites workCrystal Structure of Vδ1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human γδ T CellsQ27680609
The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T CellsQ27682926
Regulation of cutaneous malignancy by gammadelta T cellsQ28188439
Immunosurveillance and immunoregulation by gammadelta T cellsQ28292156
Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cellsQ28660812
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trialsQ30982699
V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transferQ71668739
Reconstruction of human mammary tissues in a mouse modelQ80092812
Characterization of the gammadelta T cell response to acute leukemiaQ81575021
Check MAIT.Q33630962
Quantification of epithelial cell differentiation in mammary glands and carcinomas from DMBA- and MNU-exposed ratsQ34056061
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.Q34943802
Anatomical localization of progenitor cells in human breast tissue reveals enrichment of uncommitted cells within immature lobulesQ35000334
Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acidQ35431110
The non-protein coding breast cancer susceptibility locus Mcs5a acts in a non-mammary cell-autonomous fashion through the immune system and modulates T-cell homeostasis and functionsQ35608722
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasisQ35763387
Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observationsQ35770336
Defining the cellular precursors to human breast cancerQ35778960
Leukocyte composition of human breast cancerQ35779386
High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epitheliumQ35797147
Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolismQ35889808
Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cellsQ36370502
CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patientsQ36399628
Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicityQ36490747
Processing of human reduction mammoplasty and mastectomy tissues for cell cultureQ36639586
Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neckQ36648706
Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigensQ36732656
Curriculum vitae of intestinal intraepithelial T cells: their developmental and behavioral characteristicsQ36732684
Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancerQ36800215
Exploring the anti-tumour activity of bisphosphonates in early breast cancer.Q37142755
The utility of comparative genetics to inform breast cancer prevention strategiesQ37397442
Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesisQ37426789
Immune cell quantitation in normal breast tissue lobules with and without lobulitis.Q37656390
Bisphosphonates and breast cancer incidence and recurrenceQ37964829
Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cellsQ39313746
High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo.Q39529604
Activation of γδ T cells by bisphosphonates.Q39924204
Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancerQ39990395
Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.Q40106388
Crucial role of TCR gamma chain junctional region in prenyl pyrophosphate antigen recognition by gamma delta T cellsQ41029784
Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrinQ41429601
IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils RecruitmentQ41549864
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study.Q43073125
V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells.Q43162657
Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo.Q44575984
Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blastsQ47954287
Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesisQ60241749
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectorganoidQ11293125
breast carcinomaQ18555947
P304page(s)305-316
P577publication date2016-01-25
P1433published inCancer Prevention ResearchQ2665103
P1476titleAnalysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate
P478volume9

Reverse relations

cites work (P2860)
Q40146526Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model
Q90616712An innate-like Vδ1+ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer
Q40207403Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells.
Q37304964Leveraging premalignant biology for immune-based cancer prevention
Q49838268Mixed Aryl Phosphonate Prodrugs of a Butyrophilin Ligand
Q58748503Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells
Q58737628Organoid technology and applications in cancer research
Q52564853Organoids in cancer research.
Q92097336Organoids in immunological research
Q38857539Precancer Atlas to Drive Precision Prevention Trials.
Q92723894Preclinical Modelling of PDA: Is Organoid the New Black?
Q59806979Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells
Q91698737Xenograft and organoid model systems in cancer research

Search more.